Skip to main content

From "flights" to earning more miles. New perspectives on Cannabidiol (CBD) use.



A review, recently published  in the Journal of Cannabis Research, focuses on the use of cannabidiol (CBD) for therapeutic purposes. Also examines the clinical evidence supporting its effectiveness in various conditions.

Currently, only one CBD product called Epidiolex is approved to treat seizures in specific syndromes.

This review highlights the areas where purified CBD has the most clinical evidence for its potential benefits.

These include:

  • Anxiety (positive data from 24 different studies)
  • Psychosis and schizophrenia (positive data from 9),
  • PTSD (positive data from 6), and
  • Substance abuse (positive data from 5 ).
Since the 1970s, researchers have studied how cannabidiol (CBD) affects anxiety and stress in both healthy volunteers and patient groups. Acute dosages of CBD have been shown in investigations involving healthy volunteers to lessen the anxiety that tetrahydrocannabinol (THC) administration causes.

CBD taken orally in a single dose was found effective in reducing anxiety related to public speaking. It also contributed to the extinction of traumatic memories.

According to functional brain imaging studies, CBD may have anxiolytic effects since it decreased brain activity in areas of the brain linked to fear and anxiety.

Both an acute and a seven-day oral CBD treatment in healthy males decreased resting blood pressure and blood pressure response to stress.

The most current research on healthy volunteers, however, did not find any measurable anxiolytic effects of CBD. It is important to note that most of the participants in these experiments were female, and new preclinical data show the anxiolytic effects of CBD may be stronger in male rats.

The effects of CBD on anxiety were examined in several trials. While some produced unfavorable findings, individuals with Parkinson’s disease, heroin use disorder, and generalized social anxiety disorder (SAD) all reported beneficial outcomes.

In these patients, CBD was found to reduce cravings, anxiety brought on by public speaking, negative assessment, cognitive impairment, and subjective anxiety.

In conclusion, there is conclusive evidence that a single dose of CBD can reduce blood pressure and anxiety in healthy volunteers.

CBD has shown promising preliminary in SAD patients and has produced mixed results in anxiety associated with substance abuse and other conditions.

Ongoing trials are investigating the effects of CBD in various conditions, such as SAD, pediatric epilepsy, advanced breast cancer, anorexia nervosa, bipolar disorder, and Alzheimer’s disease, which will contribute to the growing evidence base on the use of CBD for anxiety-related conditions.

The review notes, also, that there is limited evidence or lack of support for the use of purified oral CBD in pain management (especially as an acute analgesic), the treatment of COVID symptoms, cancer, Huntington’s disease, or type 2 diabetes.

As usual, to establish the efficacy of purified CBD in various indications, larger trials are needed.

Source
O’Sullivan, S.E., Jensen, S.S., Nikolajsen, G.N. et al. The therapeutic potential of purified cannabidiol. J Cannabis Res 5, 21 (2023). https://doi.org/10.1186/s42238-023-00186-9

Comments

Popular posts from this blog

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable

The safety of aspartame is under review by WHO after conflicting findings.

Aspartame, a sweetener with health effects Since 1981, the WHO expert committee on additives has confirmed the safety of aspartame consumption within acceptable daily limits. The international organization has established that the acceptable daily intake (ADI) of aspartame is 40 milligrams per kilogram of body weight. This means that a person can consume up to 40 mg of aspartame per kilogram of their body weight per day without risking their health. For example, if someone weighs 60 kilos, the allowable amount of aspartame would be 2,400 milligrams (40 mg/kg x 60 kg). In recent years, several studies have been carried out on the effects of aspartame on health. The Food and Drug Administration (FDA) has reviewed the scientific evidence related to the safety of this sweetener five times since its approval in 1981, and has concluded that it remains safe for use. However, it is being studied again. It has an especially important use in low-calorie beverages consumed by children and pregnan

Multivitamins Can Improve Memory in Older Adults

A recent clinical trial called COSMOS suggests that taking multivitamins may improve memory and slow cognitive aging in older adults.  The trial involved 3,500 participants aged 60 or older and found that the multivitamin group performed better on memory tests compared to the placebo group.  The benefits were equivalent to slowing age-related memory loss by about 3 years.  The study also noted that individuals with a history of cardiovascular disease experienced the greatest benefits.  It's important to remember that multivitamins should not replace a healthy lifestyle, and high doses of isolated micronutrients may not provide the same benefits.  The trial found that multivitamins were safe to use, and further research is needed to understand who will benefit the most and the underlying mechanisms involved. Source:  ok-Kin Yeung, Daniel M. Alschuler, Melanie Wall, Heike Luttmann-Gibson, Trisha Copeland, Christiane Hale, Richard P. Sloan, Howard D. Sesso, JoAnn E. Manson, Adam M. B